Vista Pharmaceuticals Ltd. engages in the manufacture and market of pharmaceutical products. The company is headquartered in Hyderabad, Telangana. The company went IPO on 2003-07-21. The firm also sells the products to its related companies, which are engaged in the manufacture of formulations. The company offers over the counter and prescription generic drug products, consisting of tablets, capsules and liquids covering various therapeutic categories. Its products include tablet dosage forms in the United States market, such as Sulfamethoxazole & Trimethoprim, Acetaminophen, Bismuth Subsalicylate, Bismuth Subgallate, Ferrous Gluconate, Ferrous Sulfate, Pyrantel Pamoate and Isoxsuprine HCl and tablet dosage forms in the non-United States market, such as Aspirin, Atenolol, Mebendazole, Nefidipine, Quinine Sulfate, Ranitidine HCl, Magnesium Trisilicate Compound, Aluminium Hydroxide, Folic Acid and Captopril. Its capsule dosage forms in the non-United States market include Indomethacin, Piroxicam and Nefidipine.

524711.BO Profile, Market Tickers and Other

524711.BO profile